JP2018109050A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018109050A5 JP2018109050A5 JP2018034436A JP2018034436A JP2018109050A5 JP 2018109050 A5 JP2018109050 A5 JP 2018109050A5 JP 2018034436 A JP2018034436 A JP 2018034436A JP 2018034436 A JP2018034436 A JP 2018034436A JP 2018109050 A5 JP2018109050 A5 JP 2018109050A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- och
- opr
- oet
- ome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- FUXJMHXHGDAHPD-UHFFFAOYSA-N pyrimidine-2-carboxamide Chemical class NC(=O)C1=NC=CC=N1 FUXJMHXHGDAHPD-UHFFFAOYSA-N 0.000 claims 5
- 229910004673 OPr Inorganic materials 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 4
- 239000001226 triphosphate Substances 0.000 claims 4
- 125000002103 4,4'-dimethoxytriphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)(C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims 3
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 3
- 235000011178 triphosphate Nutrition 0.000 claims 3
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 claims 3
- 150000001540 azides Chemical class 0.000 claims 1
Claims (5)
- 以下の構造を持つC−5修飾アミノカルボニルピリミジン:
R’は、−H、−Ac、−Bz、−C(O)CH2OCH3および−SiMe2tBuからなる群より選択され;
R”は、H、DMT、及び三リン酸(−P(O)(OH)−O−P(O)(OH)−O−P(O)(OH)2)又はその塩からなる群より選択され;
Xは、−H、−OH、−OMe、−O−アリル、−F、−OEt、−OPr、−OCH2CH2OCH3、及び−アジドからなる群より選択され;
Rは、−(CH2)n−RX1からなる群より選択され;
RX1は:
*は、RX1基の(CH2)nへの付加点を示し;
RX4は、分岐鎖又は直鎖の低級アルキル(C1−C20)からなる群より選択され;そして、
n=0〜10である。 - 以下の構造を持つC−5修飾アミノカルボニルピリミジン:
R’は、−H、−Ac、−Bz、−C(O)CH 2 OCH 3 および−SiMe 2 tBuからなる群より選択され;
R”は、H、DMT、及び三リン酸(−P(O)(OH)−O−P(O)(OH)−O−P(O)(OH) 2 )又はその塩からなる群より選択され;
Xは、−H、−OH、−OMe、−O−アリル、−F、−OEt、−OPr、−OCH 2 CH 2 OCH 3 、及び−アジドからなる群より選択され;
Rは、−(CH 2 ) n −R X1 からなる群より選択され;
R X1 は:
*は、R X1 基の(CH 2 ) n への付加点を示し;
R X4 は、分岐鎖又は直鎖の低級アルキル(C1−C20)からなる群より選択され;そして、
n=0〜10である。 - 以下の構造を持つC−5修飾アミノカルボニルピリミジンの3’−ホスホロアミダイト:
R”は、H、DMT、及び三リン酸(−P(O)(OH)−O−P(O)(OH)−O−P(O)(OH)2)又はその塩からなる群より選択され;
Xは、−H、−OH、−OMe、−O−アリル、−F、−OEt、−OPr、−OCH2CH2OCH3、及び−アジドからなる群より選択され;
Rは、−(CH2)n−RX1からなる群より選択され;
RX1は:
*は、RX1基の(CH2)nへの付加点を示し;
RX4は、分岐鎖又は直鎖の低級アルキル(C1−C20)からなる群より選択され;そして、
n=0〜10である。 - n=0、1又は2である、請求項1から4のいずれかに記載されるC−5修飾アミノカルボニルピリミジン。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32314510P | 2010-04-12 | 2010-04-12 | |
US61/323,145 | 2010-04-12 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016041782A Division JP6352324B2 (ja) | 2010-04-12 | 2016-03-04 | 5位修飾ピリミジンとその使用 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2018109050A JP2018109050A (ja) | 2018-07-12 |
JP2018109050A5 true JP2018109050A5 (ja) | 2018-08-23 |
JP7025818B2 JP7025818B2 (ja) | 2022-02-25 |
Family
ID=44798979
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013505029A Active JP6012591B2 (ja) | 2010-04-12 | 2011-04-12 | β−NGFに対するアプタマー及びβ−NGF介在疾患及び障害の治療におけるその使用 |
JP2013505056A Active JP5901610B2 (ja) | 2010-04-12 | 2011-04-12 | 5位修飾ピリミジンとその使用 |
JP2016041782A Active JP6352324B2 (ja) | 2010-04-12 | 2016-03-04 | 5位修飾ピリミジンとその使用 |
JP2018034436A Active JP7025818B2 (ja) | 2010-04-12 | 2018-02-28 | 5位修飾ピリミジンとその使用 |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013505029A Active JP6012591B2 (ja) | 2010-04-12 | 2011-04-12 | β−NGFに対するアプタマー及びβ−NGF介在疾患及び障害の治療におけるその使用 |
JP2013505056A Active JP5901610B2 (ja) | 2010-04-12 | 2011-04-12 | 5位修飾ピリミジンとその使用 |
JP2016041782A Active JP6352324B2 (ja) | 2010-04-12 | 2016-03-04 | 5位修飾ピリミジンとその使用 |
Country Status (23)
Country | Link |
---|---|
US (7) | US20110275794A1 (ja) |
EP (3) | EP2558478B1 (ja) |
JP (4) | JP6012591B2 (ja) |
KR (4) | KR20130043099A (ja) |
CN (4) | CN107033204A (ja) |
AR (1) | AR081452A1 (ja) |
AU (2) | AU2011240774B2 (ja) |
BR (2) | BR112012025872B8 (ja) |
CA (3) | CA2793451A1 (ja) |
CO (1) | CO6630139A2 (ja) |
DK (1) | DK2558478T3 (ja) |
EA (1) | EA022429B1 (ja) |
ES (3) | ES2610159T3 (ja) |
HK (2) | HK1201740A1 (ja) |
IL (5) | IL222339A (ja) |
MX (3) | MX2020003168A (ja) |
MY (1) | MY160608A (ja) |
NO (1) | NO2558478T3 (ja) |
NZ (1) | NZ602618A (ja) |
SG (3) | SG184089A1 (ja) |
TW (6) | TWI505833B (ja) |
UA (1) | UA105290C2 (ja) |
WO (2) | WO2011130289A1 (ja) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5993279A (ja) * | 1982-11-17 | 1984-05-29 | 富士通株式会社 | ロボツトによるカ−ド,レシ−ト分離取出し方法 |
US20110136099A1 (en) | 2007-01-16 | 2011-06-09 | Somalogic, Inc. | Multiplexed Analyses of Test Samples |
US7947447B2 (en) | 2007-01-16 | 2011-05-24 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
US8975026B2 (en) | 2007-01-16 | 2015-03-10 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
US8404830B2 (en) * | 2007-07-17 | 2013-03-26 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
CA2793451A1 (en) | 2010-04-12 | 2011-10-20 | Somalogic, Inc. | Aptamers to .beta.-ngf and their use in treating .beta.-ngf mediated diseases and disorders |
CA2817002C (en) * | 2010-11-05 | 2019-01-15 | Miragen Therapeutics | Base modified oligonucleotides |
US11214610B2 (en) | 2010-12-01 | 2022-01-04 | H. Lundbeck A/S | High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris |
US9067988B2 (en) | 2010-12-01 | 2015-06-30 | Alderbio Holdings Llc | Methods of preventing or treating pain using anti-NGF antibodies |
EP2646468B1 (en) | 2010-12-01 | 2018-07-25 | AlderBio Holdings LLC | Anti-ngf compositions and use thereof |
US9539324B2 (en) | 2010-12-01 | 2017-01-10 | Alderbio Holdings, Llc | Methods of preventing inflammation and treating pain using anti-NGF compositions |
US9078878B2 (en) | 2010-12-01 | 2015-07-14 | Alderbio Holdings Llc | Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75 |
US9884909B2 (en) | 2010-12-01 | 2018-02-06 | Alderbio Holdings Llc | Anti-NGF compositions and use thereof |
JP6587934B2 (ja) | 2012-03-28 | 2019-10-09 | ソマロジック・インコーポレーテッド | Pdgfおよびvegf結合アプタマー、および、pdgfおよびvegfが介在する病気の治療へのそれらの使用 |
CA2867481A1 (en) | 2012-04-13 | 2013-10-17 | Somalogic, Inc. | Tuberculosis biomarkers and uses thereof |
KR101556339B1 (ko) | 2012-07-02 | 2015-10-13 | 국립대학법인 울산과학기술대학교 산학협력단 | 페리오스틴에 대한 압타머 및 이를 포함하는 항암제 조성물 |
US10942184B2 (en) | 2012-10-23 | 2021-03-09 | Caris Science, Inc. | Aptamers and uses thereof |
WO2014068408A2 (en) | 2012-10-23 | 2014-05-08 | Caris Life Sciences Switzerland Holdings, S.A.R.L. | Aptamers and uses thereof |
EP2935628B1 (en) | 2012-12-19 | 2018-03-21 | Caris Life Sciences Switzerland Holdings GmbH | Compositions and methods for aptamer screening |
EP2970979B1 (en) * | 2013-03-14 | 2018-11-21 | Somalogic, Inc. | Aptamers that bind to il-6 and their use in treating or diagnosing il-6 mediated conditions |
TWI594975B (zh) | 2013-04-24 | 2017-08-11 | 第一三共股份有限公司 | 二羧酸化合物 |
WO2014177510A2 (en) * | 2013-05-03 | 2014-11-06 | Creabilis Sa | Polymer conjugates of indolocarbazole compounds in the treatment of pruritus |
GB201312295D0 (en) * | 2013-07-09 | 2013-08-21 | Syntaxin Ltd | Suppression of itch |
WO2015035305A1 (en) | 2013-09-09 | 2015-03-12 | Somalogic, Inc. | Pdgf and vegf aptamers having improved stability and their use in treating pdgf and vegf mediated diseases and disorders |
EP3049523B1 (en) * | 2013-09-24 | 2019-08-07 | Somalogic, Inc. | Multiaptamer target detection |
JP2015062364A (ja) * | 2013-09-25 | 2015-04-09 | Necソリューションイノベータ株式会社 | クレンブテロールに結合する核酸分子およびその用途 |
JP2015062365A (ja) * | 2013-09-25 | 2015-04-09 | Necソリューションイノベータ株式会社 | ラクトパミンに結合する核酸分子およびその用途 |
WO2015066001A1 (en) * | 2013-10-29 | 2015-05-07 | Albert Einstein College Of Medicine Of Yeshiva University | Nucleic acid-scaffolded small molecule libraries |
EP3071588A4 (en) * | 2013-11-21 | 2017-08-02 | Somalogic, Inc. | Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto |
CA2943772C (en) * | 2014-03-24 | 2022-07-19 | Ribomic Inc. | Aptamer for fgf2 and use thereof |
NO2718257T3 (ja) | 2014-05-30 | 2018-04-14 | ||
CA2955252A1 (en) | 2014-08-25 | 2016-03-03 | Aimmune Therapeutics, Inc. | Egg protein formulations and methods of manufacture thereof |
CN104561013A (zh) * | 2015-01-05 | 2015-04-29 | 中国人民解放军南京军区福州总医院 | 基于高通量测序技术进行核酸适配体序列优化的方法 |
EP3414229B1 (en) | 2016-02-09 | 2021-06-16 | Pharmakea, Inc. | Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof |
AU2017233994B2 (en) * | 2016-03-14 | 2021-02-18 | Somalogic Operating Co., Inc. | Compounds and Methods for the Synthesis of 5-(N-Protected-Tryptaminocarboxyamide)-2'-Deoxyuridine Phosphoramidite for Incorporation into a Nucleic Acid |
CN107663220B (zh) * | 2016-07-27 | 2020-10-02 | 上海伯豪医学检验所有限公司 | 修饰碱基、包含修饰碱基的核酸、适配体及其应用 |
US11028395B2 (en) | 2016-10-24 | 2021-06-08 | Biois Co., Ltd. | TNF-alpha-binding aptamer, and therapeutic use for same |
CN110249082B (zh) | 2016-12-01 | 2023-07-07 | 诺迪勒思附属公司 | 测定蛋白质的方法 |
CN108299518A (zh) * | 2018-02-02 | 2018-07-20 | 王成宇 | 一种2`-脱氧-β-尿苷的合成方法 |
JP7120531B2 (ja) | 2018-02-12 | 2022-08-17 | アプタキュア セラピューティクス リミテッド | スクレロスチンに対するアプタマー及びその使用 |
WO2019246289A1 (en) * | 2018-06-22 | 2019-12-26 | Somalogic, Inc. | Improved proteomic multiplex assays |
AU2020245346A1 (en) | 2019-03-22 | 2021-09-09 | Somalogic Operating Co., Inc. | Reducing intersample analyte variability in complex biological matrices |
WO2020236544A1 (en) | 2019-05-17 | 2020-11-26 | Somalogic, Inc. | Controlling intersample analyte variability in complex biological matrices |
CA3182266A1 (en) | 2020-06-11 | 2021-12-16 | Vadim Lobanov | Methods and systems for computational decoding of biological, chemical, and physical entities |
EP4281774A2 (en) | 2021-01-20 | 2023-11-29 | Nautilus Subsidiary, Inc. | Methods for biomolecule quantitation |
AU2022209365A1 (en) | 2021-01-21 | 2023-07-20 | Nautilus Subsidiary, Inc. | Systems and methods for biomolecule preparation |
JP2024514405A (ja) | 2021-03-11 | 2024-04-02 | ノーティラス・サブシディアリー・インコーポレイテッド | 生体分子保持のためのシステム及び方法 |
JP2024511622A (ja) | 2021-03-25 | 2024-03-14 | アプタキュア セラピューティクス リミテッド | in vivo半減期が延長された核酸分子コンジュゲート |
CN113481204B (zh) * | 2021-07-02 | 2022-08-12 | 湖南赛奥维生物技术有限公司 | 一种蛋白的核酸适配体、其衍生物及其应用 |
CA3227872A1 (en) | 2021-09-09 | 2023-03-16 | James Henry JOLY | Characterization and localization of protein modifications |
WO2023049073A1 (en) | 2021-09-22 | 2023-03-30 | Nautilus Biotechnology, Inc. | Methods and systems for determining polypeptide interactions |
CN117916377A (zh) | 2021-09-26 | 2024-04-19 | 安沛治疗有限公司 | 针对dkk1的适体及其用途 |
US20230149883A1 (en) | 2021-11-03 | 2023-05-18 | Nautilus Biotechnology, Inc. | Systems and methods for surface structuring |
WO2023192917A1 (en) | 2022-03-29 | 2023-10-05 | Nautilus Subsidiary, Inc. | Integrated arrays for single-analyte processes |
US20230360732A1 (en) | 2022-04-25 | 2023-11-09 | Nautilus Subsidiary, Inc. | Systems and methods for assessing and improving the quality of multiplex molecular assays |
WO2023250364A1 (en) | 2022-06-21 | 2023-12-28 | Nautilus Subsidiary, Inc. | Method for detecting analytes at sites of optically non-resolvable distances |
WO2024059655A1 (en) | 2022-09-15 | 2024-03-21 | Nautilus Subsidiary, Inc. | Characterizing accessibility of macromolecule structures |
WO2024073599A1 (en) | 2022-09-29 | 2024-04-04 | Nautilus Subsidiary, Inc. | Preparation of array surfaces for single-analyte processes |
Family Cites Families (97)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4267171A (en) | 1979-07-02 | 1981-05-12 | The Regents Of The University Of California | C-5 Substituted cytosine nucleosides |
US4415732A (en) | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
US4711955A (en) | 1981-04-17 | 1987-12-08 | Yale University | Modified nucleotides and methods of preparing and using same |
US5023243A (en) | 1981-10-23 | 1991-06-11 | Molecular Biosystems, Inc. | Oligonucleotide therapeutic agent and method of making same |
US4594339A (en) | 1982-04-06 | 1986-06-10 | Sloan-Kettering Institute For Cancer Research | Anti-herpes virus compositions containing 5-substituted 1-2'(deoxy-2-'-substituted-β-d-arabinofuranosyl)pyrimedene nucleosides |
US5599720A (en) | 1982-08-27 | 1997-02-04 | Multilyte Limited | Measurement of analyte concentration |
US4948882A (en) | 1983-02-22 | 1990-08-14 | Syngene, Inc. | Single-stranded labelled oligonucleotides, reactive monomers and methods of synthesis |
DE3329892A1 (de) | 1983-08-18 | 1985-03-07 | Köster, Hubert, Prof. Dr., 2000 Hamburg | Verfahren zur herstellung von oligonucleotiden |
US4828979A (en) | 1984-11-08 | 1989-05-09 | Life Technologies, Inc. | Nucleotide analogs for nucleic acid labeling and detection |
US4737453A (en) | 1984-12-12 | 1988-04-12 | Immunomedics, Inc. | Sandwich immunoassay utilizing a separation specific binding substance |
DE3588239T3 (de) | 1985-03-30 | 2007-03-08 | Kauffman, Stuart A., Santa Fe | Verfahren zum Erhalten von DNS, RNS, Peptiden, Polypeptiden oder Proteinen durch DMS-Rekombinant-Verfahren |
US5093232A (en) | 1985-12-11 | 1992-03-03 | Chiron Corporation | Nucleic acid probes |
US4752566A (en) | 1985-12-17 | 1988-06-21 | Genetics Institute, Inc. | Displacement polynucleotide method and reagent complex employing labeled probe polynucleotide |
US5047519A (en) | 1986-07-02 | 1991-09-10 | E. I. Du Pont De Nemours And Company | Alkynylamino-nucleotides |
US4997818A (en) | 1987-09-21 | 1991-03-05 | The University Hospital | Therapeutic method for selectively treating terminal deoxynucleotidyl transferase-positive neoplastic leukemias and lymphomas |
SE8802173D0 (sv) | 1988-06-10 | 1988-06-10 | Astra Ab | Pyrimidine derivatives |
EP0476071A4 (en) * | 1989-06-05 | 1992-11-04 | Gilead Sciences, Inc. | Exonuclease-resistant oligonucleotides and methods for preparing the same |
US5118672A (en) | 1989-07-10 | 1992-06-02 | University Of Georgia Research Foundation | 5'-diphosphohexose nucleoside pharmaceutical compositions |
US5134066A (en) | 1989-08-29 | 1992-07-28 | Monsanto Company | Improved probes using nucleosides containing 3-dezauracil analogs |
CA2071483C (en) | 1989-10-24 | 2001-04-17 | Mark Matteucci | Oligonucleotide analogs with novel linkages |
DE69108014T2 (de) | 1990-03-13 | 1995-07-06 | Acic Canada Inc | Verfahren zur herstellung von nucleosiden und ihre analogen. |
EP0537299A1 (en) | 1990-03-29 | 1993-04-21 | Gilead Sciences, Inc. | Oligonucleotide-transport agent disulfide conjugates |
US5496938A (en) | 1990-06-11 | 1996-03-05 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands to HIV-RT and HIV-1 rev |
US5660985A (en) | 1990-06-11 | 1997-08-26 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands containing modified nucleotides |
US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
US5580737A (en) | 1990-06-11 | 1996-12-03 | Nexstar Pharmaceuticals, Inc. | High-affinity nucleic acid ligands that discriminate between theophylline and caffeine |
EP1493825A3 (en) | 1990-06-11 | 2005-02-09 | Gilead Sciences, Inc. | Method for producing nucleic acid ligands |
US6030776A (en) | 1990-06-11 | 2000-02-29 | Nexstar Pharmaceuticals, Inc. | Parallel SELEX |
US5705337A (en) | 1990-06-11 | 1998-01-06 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chemi-SELEX |
US5567588A (en) | 1990-06-11 | 1996-10-22 | University Research Corporation | Systematic evolution of ligands by exponential enrichment: Solution SELEX |
US5476766A (en) | 1990-06-11 | 1995-12-19 | Nexstar Pharmaceuticals, Inc. | Ligands of thrombin |
US5861254A (en) | 1997-01-31 | 1999-01-19 | Nexstar Pharmaceuticals, Inc. | Flow cell SELEX |
US6346611B1 (en) | 1990-06-11 | 2002-02-12 | Gilead Sciences, Inc. | High affinity TGfβ nucleic acid ligands and inhibitors |
US5138045A (en) | 1990-07-27 | 1992-08-11 | Isis Pharmaceuticals | Polyamine conjugated oligonucleotides |
AU1456092A (en) | 1991-02-21 | 1992-09-15 | Gilead Sciences, Inc. | Aptamers specific for thrombin and methods of use |
US5840867A (en) * | 1991-02-21 | 1998-11-24 | Gilead Sciences, Inc. | Aptamer analogs specific for biomolecules |
AU1435492A (en) | 1991-02-21 | 1992-09-15 | Gilead Sciences, Inc. | Aptamer specific for biomolecules and method of making |
US5582981A (en) | 1991-08-14 | 1996-12-10 | Gilead Sciences, Inc. | Method for identifying an oligonucleotide aptamer specific for a target |
US5412087A (en) | 1992-04-24 | 1995-05-02 | Affymax Technologies N.V. | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
EP1256589A3 (en) | 1991-11-26 | 2003-09-17 | Isis Pharmaceuticals, Inc. | Oligomers containing modified pyrimidines |
US5580972A (en) | 1993-06-14 | 1996-12-03 | Nexstar Pharmaceuticals, Inc. | Purine nucleoside modifications by palladium catalyzed methods |
US5428149A (en) | 1993-06-14 | 1995-06-27 | Washington State University Research Foundation | Method for palladium catalyzed carbon-carbon coulping and products |
US5719273A (en) | 1993-06-14 | 1998-02-17 | Nexstar Pharmaceuticals, Inc. | Palladium catalyzed nucleoside modifications methods using nucleophiles and carbon monoxide |
US5801154A (en) | 1993-10-18 | 1998-09-01 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of multidrug resistance-associated protein |
US5596091A (en) | 1994-03-18 | 1997-01-21 | The Regents Of The University Of California | Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides |
US5658738A (en) | 1994-05-31 | 1997-08-19 | Becton Dickinson And Company | Bi-directional oligonucleotides that bind thrombin |
JP4899014B2 (ja) * | 1995-06-02 | 2012-03-21 | イーシー・テクノロジー・エルエルシー | 求核試薬および一酸化炭素を用いるパラジウム触媒ヌクレオシド修飾方法 |
US5962225A (en) | 1995-10-27 | 1999-10-05 | Cygene, Inc. | Methods and compositions for detection of specific nucleotide sequences |
US5945527A (en) * | 1996-05-30 | 1999-08-31 | Nexstar Pharmaceuticals, Inc. | Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide |
US6794499B2 (en) * | 1997-09-12 | 2004-09-21 | Exiqon A/S | Oligonucleotide analogues |
US20070166741A1 (en) | 1998-12-14 | 2007-07-19 | Somalogic, Incorporated | Multiplexed analyses of test samples |
US6020483A (en) | 1998-09-25 | 2000-02-01 | Nexstar Pharmaceuticals, Inc. | Nucleoside modifications by palladium catalyzed methods |
US6175001B1 (en) | 1998-10-16 | 2001-01-16 | The Scripps Research Institute | Functionalized pyrimidine nucleosides and nucleotides and DNA's incorporating same |
US6734172B2 (en) | 1998-11-18 | 2004-05-11 | Pacific Northwest Research Institute | Surface receptor antigen vaccines |
US20040120891A1 (en) * | 1998-12-21 | 2004-06-24 | Craig Hill | Compounds for intracellular delivery of therapeutic moieties to nerve cells |
JP3485023B2 (ja) * | 1999-05-20 | 2004-01-13 | 東亞合成株式会社 | ヌクレオシド化合物 |
US20030054360A1 (en) | 1999-01-19 | 2003-03-20 | Larry Gold | Method and apparatus for the automated generation of nucleic acid ligands |
AU2001259068A1 (en) * | 2000-04-13 | 2001-10-30 | Pharmasset, Ltd. | 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections |
US6376190B1 (en) | 2000-09-22 | 2002-04-23 | Somalogic, Inc. | Modified SELEX processes without purified protein |
AU2002360272A1 (en) | 2001-10-10 | 2003-04-22 | Superarray Bioscience Corporation | Detecting targets by unique identifier nucleotide tags |
EP1481090A4 (en) | 2002-02-15 | 2006-08-09 | Somalogic Inc | METHOD AND REAGENTS FOR DETECTING BINDING OF TARGET MOLECULES BY NUCLEIC ACID ELECTRODES |
JP3978187B2 (ja) | 2002-03-19 | 2007-09-19 | 富士通株式会社 | 機能性分子及びその製造方法 |
US7767803B2 (en) | 2002-06-18 | 2010-08-03 | Archemix Corp. | Stabilized aptamers to PSMA and their use as prostate cancer therapeutics |
CA2407825A1 (en) | 2002-10-11 | 2004-04-11 | Andrew J. Simmonds | Trap-tagging: a novel method for the identification and purification of rna-protein complexes |
AU2004204456A1 (en) | 2003-01-09 | 2004-07-29 | Invitrogen Corporation | Cellular delivery and activation polypeptide-nucleic acid complexes |
JP4119976B2 (ja) * | 2003-02-07 | 2008-07-16 | 国立大学法人群馬大学 | 5位置換ピリミジンデオキシヌクレオチド誘導体、及びそれを用いた核酸の合成方法 |
US7329742B2 (en) | 2003-09-04 | 2008-02-12 | The Regents Of The University Of California | Aptamers and methods for their in vitro selection and uses thereof |
EP1584923A3 (en) | 2004-04-07 | 2006-01-04 | Roche Diagnostics GmbH | Stabilization of biomolecules in samples |
EP1750776A2 (en) | 2004-04-30 | 2007-02-14 | Alnylam Pharmaceuticals Inc. | Oligonucleotides comprising a c5-modified pyrimidine |
JP2006117542A (ja) * | 2004-10-19 | 2006-05-11 | Pias Arise Kk | 神経成長因子産生抑制剤、並びにその神経成長因子産生抑制剤を配合した皮膚外用剤、化粧料、医薬部外品、痒み予防及び治療剤、及びアトピー性皮膚炎治療剤 |
EP1828217A2 (en) | 2004-12-16 | 2007-09-05 | Febit Biotech GmbH | Polymerase-independent analysis of the sequence of polynucleotides |
WO2007044427A2 (en) | 2005-10-05 | 2007-04-19 | Panomics, Inc. | Detection of nucleic acids from whole blood |
JP5256578B2 (ja) * | 2005-12-20 | 2013-08-07 | 大正製薬株式会社 | 掻痒性皮膚疾患の予防または治療剤 |
CA2634987C (en) | 2006-01-17 | 2017-01-03 | Somalogic, Inc. | Multiplexed analyses of test samples |
JP5372737B2 (ja) | 2006-03-13 | 2013-12-18 | オーエスアイ・フアーマシユーテイカルズ・エル・エル・シー | Egfrキナーゼ阻害剤およびegfrキナーゼ阻害剤の効果に対し腫瘍細胞を感作する薬剤を用いる併用治療 |
EP1897886A1 (en) * | 2006-09-08 | 2008-03-12 | Bayer Schering Pharma Aktiengesellschaft | Compounds as aptamer-dimers and their uses in diagnosis and therapy |
US8242258B2 (en) * | 2006-12-03 | 2012-08-14 | Agilent Technologies, Inc. | Protecting groups for RNA synthesis |
CA2673029C (en) | 2006-12-22 | 2017-03-28 | Archemix Corp. | Materials and methods for the generation of transcripts comprising modified nucleotides |
US20110136099A1 (en) | 2007-01-16 | 2011-06-09 | Somalogic, Inc. | Multiplexed Analyses of Test Samples |
US7855054B2 (en) | 2007-01-16 | 2010-12-21 | Somalogic, Inc. | Multiplexed analyses of test samples |
US7947447B2 (en) * | 2007-01-16 | 2011-05-24 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
US8975026B2 (en) | 2007-01-16 | 2015-03-10 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
EP2144921A2 (en) * | 2007-02-27 | 2010-01-20 | K.U. Leuven Research and Development | Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents |
US20090137506A1 (en) * | 2007-05-02 | 2009-05-28 | Sirna Therapeutics, Inc. | RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
US8404830B2 (en) | 2007-07-17 | 2013-03-26 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
MX2010000533A (es) * | 2007-07-17 | 2010-04-30 | Somalogic Inc | Analisis multiplexados de muestras de pruebas. |
US20090215050A1 (en) | 2008-02-22 | 2009-08-27 | Robert Delmar Jenison | Systems and methods for point-of-care amplification and detection of polynucleotides |
US8703416B2 (en) | 2008-07-17 | 2014-04-22 | Somalogic, Inc. | Method for purification and identification of sperm cells |
ES2543222T3 (es) | 2008-09-24 | 2015-08-17 | Ribomic Inc. | Aptámero para NGF y uso del mismo |
EP2542266A4 (en) | 2010-03-03 | 2013-10-23 | Somalogic Inc | 4-1BB-BINDING APTAMERS AND USE THEREOF IN THE TREATMENT OF DISEASES AND DISORDERS |
RU2615143C2 (ru) | 2010-03-24 | 2017-04-04 | Адвирна | Самодоставляющие PHKi соединения уменьшенного размера |
EP2551346B1 (en) | 2010-03-24 | 2016-01-27 | Ribomic Inc. | Aptamer for ngf and use thereof |
CA2793451A1 (en) * | 2010-04-12 | 2011-10-20 | Somalogic, Inc. | Aptamers to .beta.-ngf and their use in treating .beta.-ngf mediated diseases and disorders |
WO2011130065A1 (en) | 2010-04-12 | 2011-10-20 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF MET GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
CA2817002C (en) * | 2010-11-05 | 2019-01-15 | Miragen Therapeutics | Base modified oligonucleotides |
JP6587934B2 (ja) * | 2012-03-28 | 2019-10-09 | ソマロジック・インコーポレーテッド | Pdgfおよびvegf結合アプタマー、および、pdgfおよびvegfが介在する病気の治療へのそれらの使用 |
EP3071588A4 (en) | 2013-11-21 | 2017-08-02 | Somalogic, Inc. | Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto |
-
2011
- 2011-04-12 CA CA2793451A patent/CA2793451A1/en not_active Abandoned
- 2011-04-12 MX MX2020003168A patent/MX2020003168A/es unknown
- 2011-04-12 AU AU2011240774A patent/AU2011240774B2/en not_active Ceased
- 2011-04-12 SG SG2012068565A patent/SG184089A1/en unknown
- 2011-04-12 NO NO11769451A patent/NO2558478T3/no unknown
- 2011-04-12 DK DK11769451.3T patent/DK2558478T3/en active
- 2011-04-12 CA CA2797188A patent/CA2797188C/en active Active
- 2011-04-12 KR KR1020127026771A patent/KR20130043099A/ko not_active Application Discontinuation
- 2011-04-12 MX MX2012011779A patent/MX2012011779A/es not_active Application Discontinuation
- 2011-04-12 UA UAA201212806A patent/UA105290C2/ru unknown
- 2011-04-12 US US13/085,256 patent/US20110275794A1/en not_active Abandoned
- 2011-04-12 JP JP2013505029A patent/JP6012591B2/ja active Active
- 2011-04-12 JP JP2013505056A patent/JP5901610B2/ja active Active
- 2011-04-12 WO PCT/US2011/032143 patent/WO2011130289A1/en active Application Filing
- 2011-04-12 ES ES11769393.7T patent/ES2610159T3/es active Active
- 2011-04-12 SG SG2012074647A patent/SG184497A1/en unknown
- 2011-04-12 ES ES11769451.3T patent/ES2667491T3/es active Active
- 2011-04-12 KR KR1020197004119A patent/KR102185779B1/ko active IP Right Grant
- 2011-04-12 BR BR112012025872A patent/BR112012025872B8/pt active IP Right Grant
- 2011-04-12 EP EP11769451.3A patent/EP2558478B1/en active Active
- 2011-04-12 CN CN201610828700.9A patent/CN107033204A/zh active Pending
- 2011-04-12 CA CA3066785A patent/CA3066785A1/en active Pending
- 2011-04-12 US US13/634,618 patent/US8598140B2/en active Active
- 2011-04-12 KR KR1020127029502A patent/KR101842269B1/ko active IP Right Grant
- 2011-04-12 SG SG2014006522A patent/SG2014006522A/en unknown
- 2011-04-12 EP EP11769393.7A patent/EP2558586B1/en active Active
- 2011-04-12 CN CN201180018781.1A patent/CN102858990B/zh not_active Expired - Fee Related
- 2011-04-12 AU AU2011240677A patent/AU2011240677B2/en active Active
- 2011-04-12 NZ NZ602618A patent/NZ602618A/en not_active IP Right Cessation
- 2011-04-12 AR ARP110101235A patent/AR081452A1/es unknown
- 2011-04-12 BR BR122021003805A patent/BR122021003805B8/pt active IP Right Grant
- 2011-04-12 CN CN201410340470.2A patent/CN104069512A/zh active Pending
- 2011-04-12 KR KR1020187006712A patent/KR101952671B1/ko active IP Right Grant
- 2011-04-12 WO PCT/US2011/032017 patent/WO2011130195A1/en active Application Filing
- 2011-04-12 CN CN201180028946.3A patent/CN102985435B/zh active Active
- 2011-04-12 EA EA201291034A patent/EA022429B1/ru not_active IP Right Cessation
- 2011-04-12 TW TW100112666A patent/TWI505833B/zh not_active IP Right Cessation
- 2011-04-12 EP EP17200661.1A patent/EP3345915B1/en active Active
- 2011-04-12 MY MYPI2012004319A patent/MY160608A/en unknown
- 2011-04-12 MX MX2012011771A patent/MX2012011771A/es active IP Right Grant
- 2011-04-12 ES ES17200661T patent/ES2905656T3/es active Active
- 2011-10-11 TW TW109100780A patent/TW202019943A/zh unknown
- 2011-10-11 TW TW108120336A patent/TWI684596B/zh active
- 2011-10-11 TW TW106114660A patent/TWI643864B/zh active
- 2011-10-11 TW TW105113101A patent/TWI593701B/zh active
- 2011-10-11 TW TW107132304A patent/TWI671309B/zh active
-
2012
- 2012-10-10 IL IL222339A patent/IL222339A/en active IP Right Grant
- 2012-10-12 CO CO12181026A patent/CO6630139A2/es unknown
-
2013
- 2013-11-01 US US14/069,798 patent/US9163056B2/en active Active
-
2015
- 2015-03-06 HK HK15102316.6A patent/HK1201740A1/xx unknown
- 2015-09-08 US US14/847,150 patent/US20150376223A1/en not_active Abandoned
- 2015-10-12 IL IL242038A patent/IL242038A/en active IP Right Grant
-
2016
- 2016-03-04 JP JP2016041782A patent/JP6352324B2/ja active Active
- 2016-04-04 US US15/090,406 patent/US20160355540A1/en not_active Abandoned
-
2017
- 2017-06-06 IL IL252703A patent/IL252703A/en active IP Right Grant
- 2017-07-14 US US15/650,281 patent/US10221207B2/en active Active
- 2017-11-30 IL IL256013A patent/IL256013B/en active IP Right Grant
- 2017-11-30 IL IL256014A patent/IL256014B/en active IP Right Grant
-
2018
- 2018-02-28 JP JP2018034436A patent/JP7025818B2/ja active Active
- 2018-09-20 HK HK18112104.8A patent/HK1252803A1/zh unknown
-
2019
- 2019-01-22 US US16/254,127 patent/US20190233461A1/en not_active Abandoned